Bitdeer Technologies
BTDR
Hut 8
HUT
Bakkt Holdings
BKKT
Riot Platforms
RIOT
Canaan
CAN
Janux Therapeutics, Inc. operates preclinical stage biopharmaceutical company which engages in developing therapeutics based on the Tumor Activated T Cell Engager platform technology. The company was founded in June 2017 and is headquartered in La Jolla, CA.